World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
81
Citations
38391
World Ranking
16392
National Ranking
847

Claus Rödel publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Claus Rödel sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 488 publications — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Claus Rödel D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Claus Rödel sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 81 D-Index — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Claus Rödel is affiliated with Goethe University Frankfurt in Germany and has an extensive publication record in the field of medicine, with a strong focus on oncology and related medical specialties. Their research encompasses a wide range of topics primarily concentrated on cancer treatment and management.

The main areas of study include:

  • Medicine

Within this broad field, the subfields of study highlighted are:

  • Surgery
  • Oncology
  • Pulmonary and Respiratory Medicine
  • Radiology, Nuclear Medicine and Imaging
  • Molecular Biology

The scientist's research covers several key topics, including:

  • Colorectal and Anal Carcinomas
  • Colorectal Cancer Surgical Treatments
  • Gastric Cancer Management and Outcomes
  • Head and Neck Cancer Studies
  • Advanced Radiotherapy Techniques
  • Cancer Immunotherapy and Biomarkers
  • Colorectal Cancer Screening and Detection

Claus Rödel has published frequently in certain venues, reflecting areas of specialization and research interest. Notable journals with multiple publications are:

  • Strahlentherapie und Onkologie
  • Radiotherapy and Oncology
  • Cancers
  • Annals of Oncology
  • Clinical and Translational Radiation Oncology

Frequent collaborators in their research efforts include the following individuals:

  • Emmanouil Fokas (37 coauthored works)
  • Daniel Martin (23 coauthored works)
  • Panagiotis Balermpas (20 coauthored works)
  • Markus Diefenhardt (19 coauthored works)
  • Maximilian Fleischmann (19 coauthored works)

Some of the recent papers affiliated with Claus Rödel include:

  • ERGO2: A Prospective, Randomized Trial of Calorie-Restricted Ketogenic Diet and Fasting in Addition to Reirradiation for Malignant Glioma, 2020, International Journal of Radiation Oncology•Biology•Physics
  • Recent advances in (chemo-)radiation therapy for rectal cancer: a comprehensive review, 2020, Radiation Oncology
  • Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials, 2020, European Journal of Cancer
  • Targeted Natural Killer Cell-Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy: A Randomized Phase II Clinical Trial, 2020, Clinical Cancer Research
  • Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial, 2021, European Journal of Nutrition

Best Publications

  • Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer

    Rolf Sauer;Heinz Becker;Werner Hohenberger;Claus Rödel

  • Preoperative Versus Postoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: Results of the German CAO/ARO/AIO-94 Randomized Phase III Trial After a Median Follow-Up of 11 Years

    Rolf Sauer;Torsten Liersch;Susanne Merkel;Rainer Fietkau

  • Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data

    Monique Maas;Patty J. Nelemans;Vincenzo Valentini;Prajnan Das

  • Prognostic Significance of Tumor Regression After Preoperative Chemoradiotherapy for Rectal Cancer

    Claus Rödel;Peter Martus;Thomas Papadoupolos;Laszlo Füzesi

  • Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study.

    T G Wendt;G G Grabenbauer;C M Rödel;H J Thiel

  • Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial

    Claus Rödel;Claus Rödel;Ullrich Graeven;Rainer Fietkau;Werner Hohenberger

  • Combined-Modality Treatment and Selective Organ Preservation in Invasive Bladder Cancer: Long-Term Results

    Claus Rödel;Gerhard G. Grabenbauer;Reinhard Kühn;Thomas Papadopoulos

  • Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial

    Claus Rödel;Torsten Liersch;Heinz Becker;Rainer Fietkau

  • Prognostic Value of Pathologic Complete Response After Neoadjuvant Therapy in Locally Advanced Rectal Cancer: Long-Term Analysis of 566 ypCR Patients

    Carlo Capirci;Vincenzo Valentini;Luca Cionini;Antonino De Paoli

  • EURECCA colorectal: Multidisciplinary management: European consensus conference colon & rectum

    Cornelis J.H. Van De Velde;Petra G. Boelens;Josep M. Borras;Jan Willem Coebergh

  • Tumor Regression Grading After Preoperative Chemoradiotherapy for Locally Advanced Rectal Carcinoma Revisited: Updated Results of the CAO/ARO/AIO-94 Trial

    Emmanouil Fokas;Torsten Liersch;Rainer Fietkau;Werner Hohenberger

  • Nomograms for Predicting Local Recurrence, Distant Metastases, and Overall Survival for Patients With Locally Advanced Rectal Cancer on the Basis of European Randomized Clinical Trials

    Vincenzo Valentini;Ruud G.P.M. Van Stiphout;Guido Lammering;Maria Antonietta Gambacorta

  • Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12

    Emmanouil Fokas;Michael Allgäuer;Bülent Polat;Gunther Klautke

  • Corrections to “Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”

    R. Glynne-Jones;L. Wyrwicz;E. Tiret;G. Brown

  • [Update S3-guideline "colorectal cancer" 2008].

    W. Schmiegel;A. Reinacher-Schick;D. Arnold;U. Graeven

  • Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer.

    Franz Rödel;Jörg Hoffmann;Luitpold Distel;Martin Herrmann

  • Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer : a systematic review

    Guillaume Ploussard;Siamak Daneshmand;Jason A. Efstathiou;Harry W. Herr

  • Phase I/II Trial of Capecitabine, Oxaliplatin, and Radiation for Rectal Cancer

    Claus Rödel;Gerhard. G. Grabenbauer;Thomas Papadopoulos;Werner Hohenberger

  • Multicentre analysis of oncological and survival outcomes following anastomotic leakage after rectal cancer surgery.

    M. den Dulk;C. A. M. Marijnen;L. Collette;H. Putter

  • Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer.

    Panagiotis Balermpas;Yvonne Michel;Jens Wagenblast;Oliver Seitz

Frequent Co-Authors

Rolf Sauer
Rolf Sauer University of Erlangen-Nuremberg
Franz Rödel
Franz Rödel Goethe University Frankfurt
Rainer Fietkau
Rainer Fietkau University of Erlangen-Nuremberg
Werner Hohenberger
Werner Hohenberger University of Erlangen-Nuremberg
Claus Belka
Claus Belka Ludwig-Maximilians-Universität München
Jürgen Debus
Jürgen Debus University Hospital Heidelberg
Amir Abdollahi
Amir Abdollahi National Center for Tumor Diseases
Bruce D. Minsky
Bruce D. Minsky The University of Texas MD Anderson Cancer Center
Peter Martus
Peter Martus University of Tübingen
Arndt Hartmann
Arndt Hartmann University of Erlangen-Nuremberg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a medical degree in the USA isn’t the only path to a fulfilling healthcare career. Many students and professionals choose related roles that can be entered through flexible online programs. Options include administrative and clinical fields, from coding and billing to advanced patient care.

For those interested in healthcare administration, medical coding certification programs can be completed online, offering a fast track into hospital and clinic support roles. Nursing is another in-demand path. If you’re aiming to become a registered nurse, a nursing degree online provides an affordable and flexible entry point.

For those already qualified as nurses, advancing your career as a nurse practitioner is possible with cheapest np school online programs, which prepare you for higher responsibility and independence. Additionally, healthcare professionals seeking leadership or academic roles may consider phd in nursing online programs to broaden their expertise and prospects.

Exploring these online alternatives can open doors to diverse, rewarding roles in healthcare without the traditional time and expense of in-person programs.

Best Scientists Citing Claus Rödel

Trending Scientists